Search icon

UMOJA BIOPHARMA, INC.

Company claim

Is this your business?

Get access!

Company Details

Legal Name: UMOJA BIOPHARMA, INC.
Jurisdiction: WASHINGTON
Entity Type: FOREIGN PROFIT CORPORATION
Category: FOREIGN ENTITY
Status: Active
Formation/ Registration Date: December 3rd 2019
Expiration date: 31 Dec 2025
UBI Number: 604 465 873
ZIP code: 98109
City: Seattle
County: KING
Home State: WASHINGTON
Principal Office Street Address: Google Maps Logo 1150 EASTLAKE AVENUE E, SUITE 400, SEATTLE, WA, 98109, UNITED STATES

Contact Details

E-Mail: CLS-CTARMSEVIDENCE@WOLTERSKLUWER.COM

Nature of Business

THERAPEUTICS

Reviews Leave a review

Be the first to leave a review!

Registered Agent Information

Name Role Address
C T CORPORATION SYSTEM Registered Agent 711 CAPITOL WAY S STE 204, OLYMPIA, WA, 98501-1267, UNITED STATES

Key Officers & Management

Name Role
ANDREW SCHARENBERG MD Governing Person
RYAN CRISMAN PHD Governing Person
DAVID FONTANA PHD Governing Person
DIETER WEINAND Governing Person
LUKE EVNIN PHD Governing Person
JOHN HAMER PHD Governing Person
ANNA FRENCH PHD Governing Person
ROB GLASSMAN MD Governing Person
VALENTIN BARSAN MD Governing Person
GREG SARGEN MBA Governing Person

Trademarks

Serial Number:
97474435
Mark:
LENTISMAC
Status:
FOURTH EXTENSION - GRANTED
Mark Type:
TRADEMARK, SERVICE MARK
Application Filing Date:
2022-06-24
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
LENTISMAC

Goods And Services

For:
Manufacturing services for others in the field of pharmaceutical preparations
International Classes:
040 - Primary Class
Class Status:
Active
For:
Pharmaceutical products for the treatment of cancer
International Classes:
005 - Primary Class
Class Status:
Active
For:
Medical consulting services in the fields of immunotherapy and oncology
International Classes:
044 - Primary Class
Class Status:
Active
For:
Medical research and scientific research in the fields of immunotherapy and oncology; Medical research consulting and scientific research consulting services in...
International Classes:
042 - Primary Class
Class Status:
Active
Serial Number:
97474432
Mark:
RACR
Status:
FOURTH EXTENSION - GRANTED
Mark Type:
TRADEMARK, SERVICE MARK
Application Filing Date:
2022-06-24
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
RACR

Goods And Services

For:
Manufacturing services for others in the field of pharmaceutical preparations
International Classes:
040 - Primary Class
Class Status:
Active
For:
Pharmaceutical products for the treatment of cancer
International Classes:
005 - Primary Class
Class Status:
Active
For:
Medical consulting services in the fields of immunotherapy and oncology
International Classes:
044 - Primary Class
Class Status:
Active
For:
Medical research and scientific research in the fields of immunotherapy and oncology; Medical research consulting and scientific research consulting services in...
International Classes:
042 - Primary Class
Class Status:
Active
Serial Number:
97474431
Mark:
TUMORTAG
Status:
FOURTH EXTENSION - GRANTED
Mark Type:
TRADEMARK, SERVICE MARK
Application Filing Date:
2022-06-24
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
TUMORTAG

Goods And Services

For:
Manufacturing services for others in the field of pharmaceutical preparations
International Classes:
040 - Primary Class
Class Status:
Active
For:
Pharmaceutical products for the treatment of cancer
International Classes:
005 - Primary Class
Class Status:
Active
For:
Medical consulting services in the fields of immunotherapy and oncology
International Classes:
044 - Primary Class
Class Status:
Active
For:
Medical research and scientific research in the fields of immunotherapy and oncology; Medical research consulting and scientific research consulting services in...
International Classes:
042 - Primary Class
Class Status:
Active
Serial Number:
97474428
Mark:
VIVOVEC
Status:
FOURTH EXTENSION - GRANTED
Mark Type:
TRADEMARK, SERVICE MARK
Application Filing Date:
2022-06-24
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
VIVOVEC

Goods And Services

For:
Manufacturing services for others in the field of pharmaceutical preparations
International Classes:
040 - Primary Class
Class Status:
Active
For:
Pharmaceutical products for the treatment of cancer, all of the foregoing being gene therapy products
International Classes:
005 - Primary Class
Class Status:
Active
For:
Medical consulting services in the fields of immunotherapy and oncology
International Classes:
044 - Primary Class
Class Status:
Active
For:
Medical research and scientific research in the fields of immunotherapy and oncology; Medical research consulting and scientific research consulting services in...
International Classes:
042 - Primary Class
Class Status:
Active
Serial Number:
97372711
Mark:
U
Status:
REGISTERED
Mark Type:
TRADEMARK, SERVICE MARK
Application Filing Date:
2022-04-20
Mark Drawing Type:
Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Mark Literal Elements:
U

Goods And Services

For:
Manufacturing services for others in the field of pharmaceutical preparations
International Classes:
040 - Primary Class
Class Status:
Active
For:
Pharmaceutical products for the treatment of cancer
International Classes:
005 - Primary Class
Class Status:
Active
For:
Medical consulting services in the fields of immunotherapy and oncology
International Classes:
044 - Primary Class
Class Status:
Active
For:
Medical research and scientific research in the fields of immunotherapy and oncology; Medical research consulting and scientific research consulting services in...
International Classes:
042 - Primary Class
Class Status:
Active

Labor Condition Applications

Case Number:
I-200-24121-942802
Program:
H-1B
Job Title:
Principal Scientist
SOC (ONET/OES) code:
19-1029.02
SOC (ONET/OES) occupation title:
Molecular and Cellular Biologists
Begin Date:
2024-10-11
End Date:
2027-10-10

Employment and Wage Information

Address:
1150 Eastlake Ave E, Suite 400, Seattle, KING, WA, 98109
Wage Rate Paid to Nonimmigrant Workers:
$170,000
Per:
Year
Prevailing Wage Rate:
$114,525
See something incorrect or outdated? Let us know